Participation in peer-led therapy groups can help at-risk patients become less vulnerable for suicide according to new research to be presented at the American Psychiatric Association Annual Meeting in Honolulu.
Suicide risk assessment has become increasingly refined and utilized in public and private medical and psychiatric facilities across the nation including within the military where high suicide rates have been reported among recently returning military and older veterans.
The research examined whether identifying and reinforcing a primary care patient’s suicide protective factors, such as responsibilities toward children and family, optimism, hope, and positive coping skills, spiritual, moral, and religious factors, and social supports, may help lessen the impact of crises and depression and reduce the risk for suicide.
The study involved screening primary care patients at Department of Veterans Affairs Medical Centers for suicide risk using the Patient Health Questionnaire-2. Patients identified as at-risk were invited to a 4-week peer-led therapy group aimed at providing social support and educating patients on the importance of these protective factors and ways to integrate the factors more fully into their lives and ongoing awareness.
Data collected thus far, author Shabnam Balai, M.D., reports, are encouraging and show that by participating in a low-intensive, peer-led therapy group, primary care patients can become less vulnerable for suicide.
The research was presented at the APA Annual Meeting in Honolulu. The meeting was May 14-18, 2010.
WATCH 2011 Annual Meeting All-Access Right Here
Tuesday, May 17, 2011
Monday, May 16, 2011
Fascinating Science and Networking in Paradise
By Iqbal “Ike” Ahmed, M.D.
I am writing from the perspective of an APA member who lives in Honolulu. I am excited about so many fellow psychiatrists and other mental health providers visiting my home town and enjoying what it has to offer-Aloha, warm hospitality, friendly people, interesting culture, great weather, and beautiful surrounding such as our beaches and mountains.
My own experience of the meeting has been one of trying to make the meeting informative and enjoyable for my friends and fellow psychiatrists visiting the island. In between, I have had the opportunity to chair a few fascinating scientific sessions. In one of those a study suggests that a cognitive screening instrument, the Montreal Cognitive Assessment (MOCA) was better in the recognition of cognitive impairment in depressed patients. The importance of this is that cognitive impairment can affect function in depressed patients. I also heard that loneliness appears to be associated with increased development of dementia in a Dutch population. In another session, I heard about use of PHQ-9 used as a screening instrument to recognize depression in Kaiser patients with medical problems and then having them followed by care managers.
The most interesting thing I learnt was about the development of serum biomarkers to distinguish schizophrenia from patients with other psychiatric disorders, and from those without mental illness. This was presented by Prof. Sabine Bahn, of Cambridge and Erasmus Universities as a “Frontiers of Science Lecture”. I was fascinated about the underlying science behind this about insulin resistance, glucose uptake in the brain, oxidative stress in the neurons, and the associated changes in the serum of patients leading to a biomarker fingerprint. It is amazing, that this biomarker test is already commercially being marketed.
Well, it is now time to run along and try to get in to hear Rev. Desmond Tutu, talk about his work on the reconciliation commission in South Africa at the Convocation of Fellows. Hope to then spend an evening with friends from Mainland attending the meeting-one of my favorite parts of the Annual Meeting.
I am writing from the perspective of an APA member who lives in Honolulu. I am excited about so many fellow psychiatrists and other mental health providers visiting my home town and enjoying what it has to offer-Aloha, warm hospitality, friendly people, interesting culture, great weather, and beautiful surrounding such as our beaches and mountains.
My own experience of the meeting has been one of trying to make the meeting informative and enjoyable for my friends and fellow psychiatrists visiting the island. In between, I have had the opportunity to chair a few fascinating scientific sessions. In one of those a study suggests that a cognitive screening instrument, the Montreal Cognitive Assessment (MOCA) was better in the recognition of cognitive impairment in depressed patients. The importance of this is that cognitive impairment can affect function in depressed patients. I also heard that loneliness appears to be associated with increased development of dementia in a Dutch population. In another session, I heard about use of PHQ-9 used as a screening instrument to recognize depression in Kaiser patients with medical problems and then having them followed by care managers.
The most interesting thing I learnt was about the development of serum biomarkers to distinguish schizophrenia from patients with other psychiatric disorders, and from those without mental illness. This was presented by Prof. Sabine Bahn, of Cambridge and Erasmus Universities as a “Frontiers of Science Lecture”. I was fascinated about the underlying science behind this about insulin resistance, glucose uptake in the brain, oxidative stress in the neurons, and the associated changes in the serum of patients leading to a biomarker fingerprint. It is amazing, that this biomarker test is already commercially being marketed.
Well, it is now time to run along and try to get in to hear Rev. Desmond Tutu, talk about his work on the reconciliation commission in South Africa at the Convocation of Fellows. Hope to then spend an evening with friends from Mainland attending the meeting-one of my favorite parts of the Annual Meeting.
Children of Deployed Parents More Likely to Experience Psychiatric Hospitalization
Children of military service members are more likely to be hospitalized for a psychiatric condition when a parent has been deployed, according to a new study presented at the American Psychiatric Association Annual Meeting.
The research was scheduled for presentation in a press briefing Monday, May 16, at the 164th American Psychiatric Association Annual Meeting, which is in Honolulu May 14-18
Researchers looked at records for nearly 380,000 children ages 9 to 17 years of active duty military personnel. The children’s data was linked to the parent’s deployment records.
The odds of psychiatric hospitalization increased by 10 percent among children age 9 to 17 years when a military parent was deployed, according to the study. The odds of hospitalization increased with increasing length of a parent’s deployment.Details of this study, along with five other new research studies, will be presented at a press briefing from the APA Annual Meeting. Members of the media can attend in Room 307 of the Hawaii Convention Center at 8 am Hawaii time, Monday, May 16, or participate online at 11 AM PDT/2 pm EDT by registering at https://www2.gotomeeting.com/register/341505819.
The American Psychiatric Association is a national medical specialty society whose physician members specialize in the diagnosis, treatment, prevention, and research of mental illnesses, including substance use disorders. Visit the APA at http://www.psych.org/ and http://www.healthyminds.org/.
Labels:
children,
deployment,
military,
military family,
new research
Hawaii Study Shows Increasing Psychiatric Emergency Room Visits Among Elderly
The research was scheduled for presentation Monday, May 16, at the 164th American Psychiatric Association Annual Meeting, which is in Honolulu May 14-18. Researchers from The Queen’s Medical Center in Honolulu showed psychiatric emergency room visits by elderly patients increasing by 30 percent from 2008 to 2009.
Details of this study, along with five other new research studies, will be presented at a media briefing from the APA Annual Meeting. Members of the media can attend in Room 307 of the Hawaii Convention Center at 8 am Hawaii time, Monday, May 16, or participate online at 11 AM PDT/2 pm EDT by registering at https://www2.gotomeeting.com/register/341505819.
The American Psychiatric Association is a national medical specialty society whose physician members specialize in the diagnosis, treatment, prevention and research of mental illnesses, including substance use disorders. Visit the APA at www.psych.org and www.HealthyMinds.org.
Sunday, May 15, 2011
Study Looks at Connection between Economic Stress, Suicide
If the United States follows the pattern that occurred after the economic crisis in Japan, public health officials should watch for a significant increase in suicides, particularly among Baby Boomers, concluded a study scheduled for presentation at the American Psychiatric Association's Annual Meeting.The new research was scheduled for presentation Sunday, May 15, at the 164th American Psychiatric Association Annual Meeting, which is in Honolulu May 14-18.
Researchers looked at suicide rates in Japan during the late 1990s when that country experienced an economic downturn similar to recent trends in the United States and Europe. The study examined suicides in Japan by age, gender, and year in relation to a series of economic variables. If the U.S. rates of increased suicide approximate those in Japan, the country would experience a yearly increase of deaths due to suicide estimated at 14,610 per year, the study concluded.
Details of this study, along with five other new research studies, will be presented at a press briefing from the APA Annual Meeting. Members of the media can attend in Room 307 of the Hawaii Convention Center at 8 am Hawaii time, Monday, May 16, or participate online at 11 AM PDT/2 pm EDT by registering at https://www2.gotomeeting.com/register/341505819.
The American Psychiatric Association is a national medical specialty society whose physician members specialize in the diagnosis, treatment, prevention, and research of mental illnesses, including substance use disorders. Visit the APA at http://www.psych.org/ and http://www.healthyminds.org/.
Saturday, May 14, 2011
Case Studies: Synthetic Cannabis Linked to Extended Psychosis
Case studies indicate the recreational use of synthetic cannabis may in some cases lead to psychosis that can last for days or months in some cases, according to a study at the American Psychiatric Association Annual Meeting in Hawaii.
Researchers at the Naval Medical Center in San Diego followed ten patients hospitalized for psychosis apparently induced by the use of synthetic cannabis, commonly known as “Spice,” “K2,” “Blaze,” and “Red X Dawn.” These are plant material coated with varying combinations of synthetic cannabinoids, which act on the body in a similar way to chemicals found in cannabis. The compounds have not been approved by the FDA for human consumption and little is known about their safety.
The ten patients studied ranged in age from 21 to 25 years old and after use of “Spice” experienced ongoing psychotic symptoms, including auditory and visual hallucinations, paranoid delusions, odd or flat affect, thought blocking, disorganized speech, thoughts of suicide, insomnia, slowed reaction times, agitation and anxiety. Psychotic symptoms generally resolved between five and eight days after admission, but in some cases continued three months or longer.
The research was scheduled for presentation at 1 p.m. Saturday, May 14, at the American Psychiatric Association 164th Annual Meeting, which runs May 14-18 at the Hawaii Convention Center in Honolulu.
Researchers at the Naval Medical Center in San Diego followed ten patients hospitalized for psychosis apparently induced by the use of synthetic cannabis, commonly known as “Spice,” “K2,” “Blaze,” and “Red X Dawn.” These are plant material coated with varying combinations of synthetic cannabinoids, which act on the body in a similar way to chemicals found in cannabis. The compounds have not been approved by the FDA for human consumption and little is known about their safety.
The ten patients studied ranged in age from 21 to 25 years old and after use of “Spice” experienced ongoing psychotic symptoms, including auditory and visual hallucinations, paranoid delusions, odd or flat affect, thought blocking, disorganized speech, thoughts of suicide, insomnia, slowed reaction times, agitation and anxiety. Psychotic symptoms generally resolved between five and eight days after admission, but in some cases continued three months or longer.
The research was scheduled for presentation at 1 p.m. Saturday, May 14, at the American Psychiatric Association 164th Annual Meeting, which runs May 14-18 at the Hawaii Convention Center in Honolulu.
Labels:
drug abuse,
new research,
psychosis,
synthetic cannabis
Electronic Patient Records used to help Identify Biological Causality
Research demonstrating the use of data mining of electronic patient records to study co-morbidity, family predisposition, and finding biological causes for medical conditions otherwise hidden to the eye will be presented at the APA Annual Meeting in Honolulu.
The APA’s 164th Annual Meeting, the world’s largest psychiatric meeting, will run Saturday, May 14 to Wednesday, May 18, 2010 at the Hawaii Convention Center in Honolulu.
The study looked at 10 years of records from Mental Health Centre Sct. Hans, a regional psychiatric hospital in Denmark, on 3,290 patients’ records involving 674 different diagnoses. Of the assigned diagnoses 24% were mental and behavioral disorders. Researchers identified about 270 co-morbidities as unexpected with no know relation. These unexpected co-morbidities were further analyzed to examine whether the co-morbidity could be explained by shared genes, gene-complex, or biological pathways.
For one of these, researchers discovered a previously unrecognized shared biology underlying the two clinical conditions which can be interpreted as a shared genetic predisposition to side effects or to an autoimmune condition.
The new research posters (#NR02-60) were scheduled for presentation Saturday, May 14, at the Hawaii Convention Center.
The APA’s 164th Annual Meeting, the world’s largest psychiatric meeting, will run Saturday, May 14 to Wednesday, May 18, 2010 at the Hawaii Convention Center in Honolulu.
The study looked at 10 years of records from Mental Health Centre Sct. Hans, a regional psychiatric hospital in Denmark, on 3,290 patients’ records involving 674 different diagnoses. Of the assigned diagnoses 24% were mental and behavioral disorders. Researchers identified about 270 co-morbidities as unexpected with no know relation. These unexpected co-morbidities were further analyzed to examine whether the co-morbidity could be explained by shared genes, gene-complex, or biological pathways.
For one of these, researchers discovered a previously unrecognized shared biology underlying the two clinical conditions which can be interpreted as a shared genetic predisposition to side effects or to an autoimmune condition.
The new research posters (#NR02-60) were scheduled for presentation Saturday, May 14, at the Hawaii Convention Center.
Labels:
electronic medical records,
new research
Subscribe to:
Posts (Atom)
